methylprednisolone has been researched along with Central Nervous System Cysticercosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhir, A; Jillella, DV; Landzberg, DR | 1 |
| Jeong, SM; Kim, JS; Moon, SY; Park, SH | 1 |
| Agarwal, A; Garg, RK; Kar, AM; Prakash, S; Shukla, R; Singh, MK; Verma, R | 1 |
| Abuchanab, ME; Bergroth, B; Contardo, DM; Mazzei, ME; Melero, MJ | 1 |
1 trial(s) available for methylprednisolone and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
Intravenous methyl prednisolone in patients with solitary cysticercus granuloma: a random evaluation.
Topics: Adolescent; Anti-Inflammatory Agents; Anticonvulsants; Drug Therapy, Combination; Female; Follow-Up Studies; Granuloma; Humans; India; Injections, Intravenous; Male; Methylprednisolone; Neurocysticercosis; Prospective Studies; Seizures | 2006 |
3 other study(ies) available for methylprednisolone and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
Radiographic Improvement of Larval Cysts in Neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Anticonvulsants; Brain; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Neurocysticercosis; Neuroprotective Agents; Praziquantel; Seizures; Treatment Outcome | 2021 |
Third cranial nerve palsy from midbrain neurocysticercosis: repeated exacerbation on tapering corticosteroids.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Blepharoptosis; Cerebrospinal Fluid; Cysticercus; Diplopia; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Mesencephalon; Methylprednisolone; Middle Aged; Neurocysticercosis; Oculomotor Nerve Diseases; Praziquantel; Recurrence | 2004 |
[Neurocysticercosis].
Topics: Aged, 80 and over; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Humans; Magnetic Resonance Spectroscopy; Male; Methylprednisolone; Neurocysticercosis | 2007 |